Transaction in Own Shares • Jul 1, 2010
Transaction in Own Shares
Open in ViewerOpens in native device viewer
Contact: SE-753 18 Uppsala Torben Jörgensen, President and CEO Tel+46 18 56 59 00 Tel: +46 707 49 05 84, [email protected] www.biotage.com
Kungsgatan 76
Uppsala July 1, 2010
Biotage AB (publ) has on 30 June 2010 bought back 56,000 shares. The Company`s aggregated holding of own shares thereby amounts to 4,441,987 shares, corresponding to 5.02 percent of the total amount of shares and votes in the Company.
The total amount of shares outstanding, including shares held in treasury, amounts to 88,486,320.
Biotage discloses the information provided herein pursuant to the Swedish Securities Markets Act and/or the Swedish Financial Instruments Trading Act. The information was submitted for publication at CET 8.30 am on 1 July 2010.
About Biotage
Biotage offers solutions, knowledge and experience in the areas of analytical chemistry and medicinal chemistry. The customers include the world's largest pharmaceutical and biotech companies, and leading academic institutes. The company is headquartered in Uppsala and has subsidiaries in the US, UK and Japan. Biotage has 245 employees and had sales of 394.1 MSEK in 2009. Biotage is listed on the NASDAQ OMX Nordic Stockholm stock exchange. Website: www.biotage.com
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.